ENO2 and Alzheimer disease: Two studies (Palumbo et al., 2008; Christl et al., 2019) – investigating NSE levels in amnestic MCI regarded as a pre-stage of AD (Christl et al., 2019) – did not find any differences between patients and controls in CSF.